Small molecule screen employing patient-derived iPS hepatocytes identifies LRRK2 as a novel therapeutic target for Alpha1 Antitrypsin DeficiencyDeniz Kent, S. Tamir Rashid|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0
Small molecule screen employing patient-derived iPSC hepatocytes identifies LRRK2 as a novel therapeutic target for Alpha1 Antitrypsin DeficiencyDeniz Kent, S. Tamir Rashid|Research Square|2022Cited by 0